Compounds > perfluoromethyldecalin
Page last updated: 2024-12-06

perfluoromethyldecalin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

perfluoromethyldecalin: used to prepare synthetic surfactant with pulmonary surfactant [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID39977
SCHEMBL ID144465
MeSH IDM0113371

Synonyms (46)

Synonym
naphthalene, 1,1,2,2,3,3,4,4,4a,5,5,6,6,7,7,8,8a-heptadecafluorodecahydro-8-(trifluoromethyl)-
perfluoro-1-methyldecalin
naphthalene, heptadecafluorodecahydro(trifluoromethyl)-
naphthalene, decahydroheptadecafluoro(trifluoromethyl)-
pp 9
einecs 206-191-9
perfluoromethyldecalin
perfluoro(1-methyldecalin)
brn 2030021
heptadecafluorodecahydro-1-(trifluoromethyl)naphthalene
flutec pp9
1,1,2,2,3,3,4,4,4a,5,5,6,6,7,7,8,8a-heptadecafluorodecahydro-8-(trifluoromethyl)naphthalene
PP9 ,
1,1,2,2,3,3,4,4,4a,5,5,6,6,7,7,8,8a-heptadecafluoro-8-(trifluoromethyl)naphthalene
perfluoro(methyldecalin)
51294-16-7
heptadecafluorodecahydro(trifluoromethyl)naphthalene
perfluoro(methyldecalin), tech.
A820488
A828519
306-92-3
1,1,2,2,3,3,4,4,4a,5,5,6,6,7,7,8,8a-heptadecakis(fluoranyl)-8-(trifluoromethyl)naphthalene
naphthalene, heptadecafluorodecahydro-1-(trifluoromethyl)-
3-05-00-00269 (beilstein handbook reference)
unii-vwj68ob6tm
vwj68ob6tm ,
AKOS016015629
FT-0605958
FT-0605957
fiflow 160
perfluoro(decahydro-1-methylnaphthalene)
perfluoromethyldecalin [inci]
flutec pp 9
perfluoromethyldecaline
flutec pc9
1-(trifluoromethyl)perfluorodecalin
SCHEMBL144465
perfluoro-1-methyldecaline
1,1,2,2,3,3,4,4,4a,5,5,6,6,7,7,8,8a-heptadecafluoro-8-(trifluoromethyl)decahydronaphthalene #
naphthalene,heptadecafluorodecahydro(trifluoromethyl)-
flutec pp9 for electronic applications
mfcd00014326
DTXSID30897561
1,1,2,2,3,3,4,4,4a,5,5,6,6,7,7,8,8a-heptadecafluoro-8-(trifluoromethyl)decahydronaphthalene
Q17047843
perfluoro-1-methyl-decahydro-naphthalene
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (4)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 20.01

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index20.01 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.32 (4.65)
Search Engine Demand Index15.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (20.01)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
perfluorodecalin
perfluorodecalin: RN given refers to parent cpd without isomeric designation. perfluorodecalin : A fluorocarbon that is decalin in which every hydrogen is replaced by fluorine. Capable of dissolving large quantities of oxygen, it has been used as the basis of an artificial blood substitute.		7.1110fluorocarbonblood substitute;
solvent
tert-butylcyclohexane
[no description available]		7.1110
glycogen
glycogen : A polydisperse, highly branched glucan composed of chains of D-glucopyranose residues in alpha(1->4) glycosidic linkage, joined together by alpha(1->6) glycosidic linkages. A small number of alpha(1->3) glycosidic linkages and some cumulative alpha(1->6) links also may occur. The branches in glycogen typically contain 8 to 12 glucose residues.		1.9610
ConditionIndicatedRelationship StrengthStudiesTrials
Keratoconus
A noninflammatory, usually bilateral protrusion of the cornea, the apex being displaced downward and nasally. It occurs most commonly in females at about puberty. The cause is unknown but hereditary factors may play a role. The -conus refers to the cone shape of the corneal protrusion. (From Dorland, 27th ed)		01.9610